VI
Vimy Pharmaceuticals Corp.
VIMY · V · Healthcare / Biotechnology
2.85CAD
Price History
Full chartMarket Stats
Open2.85
Day Range2.84 – 2.85
52-Week Range2.69 – 3.00
Volume37.76K
Market Cap92.19M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.04
Dividend Yield0.00%
50-Day Avg2.77
200-Day Avg2.77
About
Vimy Pharmaceuticals Inc. manufactures complex medicines intended to treat chronic diseases and improve patient access to care. The company manufactures complex medicines and therapeutic products, enabling healthcare providers to treat chronic conditions such as diabetes and obesity while improving the sustainability of universal healthcare systems. Vimy Pharmaceuticals Inc. was incorporated in 2024 and is headquartered in Ontario, Canada.
Company Details
- SectorHealthcare
- IndustryBiotechnology
- CEOMr. Farris Smith
- Headquarters2 Bloor Street West,, Toronto, ON, Canada, M4W1J5, Canada
- Websitehttps://www.vimypharma.com
Leadership
- Mr. Farris SmithCo-Founder, President & Chair
Earnings
Key Statistics & Ratios
Market Cap92.19M
Enterprise Value91.90M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book34.48
EPS-0.04
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Shares Outstanding32.35M
Shares Float0
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%